Royalty Pharma PLC

Royalty Pharma PLC

World Rank (Aug-2026)
783
Market Cap (Aug-2026)
33.695 Billion USD
World Rank (Jan-05-2024)
1,072
Market Cap (Jan-05-2024)
16.638 Billion USD
World Rank (Jul-30-2023)
1,273
Market Cap (Jul-30-2023)
13.997 Billion USD
World Rank (Jan-07-2022)
1,178
Market Cap (Jan-07-2022)
17.292 Billion USD
World Rank (Jan-01-2021)
572
Market Cap (Jan-01-2021)
31.293 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 496
Headquarters Country
USA
Nasdaq / NYSE Code
RPRX
CEO
Pablo Legorreta
Chairman
Riggs
Employee Count
75
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
2,378 Million USD
Annual Operating Income in USD
1,560 Million USD
Annual Net Income in USD
771 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
19,621 Million USD
Total Liabilities in USD
9,906 Million USD
Total Equity in USD
9,715 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Biotechnology
Company Website
ROYALTY PHARMA PLC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Royalty Pharma is the leader in acquiring Pharmaceutical company royalties across the life sciences industry. The headquarters is in USA.

Royalty Pharma plc is a funder of biopharmaceutical industry.The company includes royalties on commercial products.

It is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.

As on 2019, Royalty Pharma has 35 employees.

Royalty Pharma annual revenue generated for period ending Dec-2022 was 2,237 million USD.

Royalty Pharma annual net income generated for period ending Dec-2022 was 42 million USD.

Annual Results Summary

ROYALTY PHARMA PLC - Annual Result Summary - in Million USD

Year Ending:Total RevenueOperating IncomeNet Income
Dec-20222,23792242
Dec-20212,2891,430619
Dec-20202,1221,595975
Dec-20191,8142,6232,349
Dec-20181,7951,3641,378
Balance Sheet Summary

ROYALTY PHARMA PLC - Balance Sheet Summary - in Million USD

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-202216,8137,2889,525
Dec-202117,5157,26710,248
Dec-202016,02011,2024,819
Dec-201912,4506,3446,106
Dec-201811,3706,8824,488
Founded Year
1996
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share